The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Mirum Pharmaceuticals Inc shares valued at $2,480,000 were sold by Peetz Christopher on Aug 11 ’25. At $62.00 per share, Peetz Christopher sold 40,000 shares. The insider’s holdings dropped to 138,641 shares worth approximately $8.99 million following the completion of this transaction.
Also, CHRISTOPHER PEETZ purchased 40,000 shares, netting a total of over 2,480,000 in proceeds.
Before that, Howe Jolanda had sold 10,000 shares from its account. In a trade valued at $580,000, the SVP, GLOBAL CONTROLLER traded Mirum Pharmaceuticals Inc shares for $58.00 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $0.16 million.
As of April 17, 2024, Stifel has initiated its “Buy” rating for MIRM. Earlier on December 18, 2023, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for MIRM stock.
Analyzing MIRM Stock Performance
On last trading session, Mirum Pharmaceuticals Inc [NASDAQ: MIRM] plunged -0.48% to $64.83. The stock’s lowest price that day was $64.29, but it reached a high of $65.72 in the same session. During the last five days, there has been a surge of approximately 8.38%. Over the course of the year, Mirum Pharmaceuticals Inc shares have jumped approximately 44.90%. Shares of the company reached a 52-week high of $67.45 on 08/12/25 and a 52-week low of $36.88 on 04/09/25.
Support And Resistance Levels for Mirum Pharmaceuticals Inc (MIRM)
According to the 24-hour chart, there is a support level at 64.09, which, if violated, would cause prices to drop to 63.36. In the upper region, resistance lies at 65.64. The next price resistance is at 66.46. RSI (Relative Strength Index) is 79.49 on the 14-day chart, showing overbought technical sentiment.
Is Mirum Pharmaceuticals Inc subject to short interest?
Stocks of Mirum Pharmaceuticals Inc saw a sharp rise in short interest on 2025-07-31 jumping by 0.12 million shares to 6.63 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 6.51 million shares. A jump of 1.83% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 17.23 of the overall float, the days-to-cover ratio (short ratio) jumped to 17.23.
Which companies own the most shares of Mirum Pharmaceuticals Inc (MIRM)?
In terms of Mirum Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 85 in the next 12 months, up nearly 30.49% from the previous closing price of $65.14. Analysts anticipate Mirum Pharmaceuticals Inc stock to reach 89 by 2025, with the lowest price target being 81. In spite of this, 9 analysts ranked Mirum Pharmaceuticals Inc stock as Buy at the end of 2025. On November 20, 2023, JP Morgan assigned a price target of “an Overweight” to the stock and resumed coverage with a $37.
